Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
KNOREX LTD.Bullish
KNOREX Ltd. entered into an exchange agreement to convert $3.15 million in existing senior unsecured promissory notes into new convertible promissory notes totaling $3,363,411. The new notes mature on January 1, 2027, and feature a conversion price linked to the stock's VWAP, which may lead to potential shareholder dilution.…more
KNOREX LTD.
KNOREX is pursuing a strategic carve-out of its subsidiary, AscendX, to establish an independently capitalized structure through external investment. Upon completion, KNOREX will eliminate the need to fund AscendX's future growth, allowing the company to refocus its resources on its core KNOREX XPO platform and AI initiatives.…more
KNOREX LTD.
KNOREX LTD.'s registration statement (File No. 333-299038) was declared effective by the SEC on September 25, 2026. This effectiveness allows the company to proceed with the issuance and offering of the related securities.…more
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
KNOREX Pursues Strategic Carve-Out of Subsidiary AscendX
KNOREX plans to spin off its subsidiary AscendX to secure independent external funding. This move aims to reduce KNOREX's financial burden while allowing it to focus resources on its core advertising platform.…more
●●●●●●●● ●●●●● ●●●●●●
KNOREX has been notified by the NYSE American that it is not in compliance with continued listing standards. This notice highlights potential risks regarding the company's future listing status.…more
●●●●●●●● ●●●●● ●●●●●●
KNOREX disclosed that its independent auditors included an explanatory paragraph regarding the company's ability to continue as a going concern in its FY2025 annual report. This disclosure highlights significant financial risks and potential instability for the company.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.